Citrobacter diversus

(redirected from Citrobacter koseri)

Cit·ro·bac·ter di·ver·'sus

a bacterial species found in feces, soil, water, sewage, and food; isolated from urine, throat, nose, sputum, and wounds; reported in cases of neonatal meningitis where it frequently is severe, resulting in brain abscess formation.

Citrobacter diversus

Microbiology A Citrobacter in soil, water, sewage and food, and an opportunistic pathogen Epidemiology C diversus is an important cause of bacterial meningitis, brain abscesses, and may cause endocarditis and hospital-acquired bacterial infections
References in periodicals archive ?
Complicated Urinary Tract Infections (cUTI), including Pyelonephritis AVYCAZ is indicated for the treatment of complicated urinary tract infections (cUTI) including pyelonephritis caused by the following susceptible microorganisms: Escherichia coli, Klebsiella pneumoniae, Citrobacter koseri, Enterobacter aerogenes, Enterobacter cloacae, Citrobacter freundii, Proteus spp.
5 TABLE 2 Frequency of Detection of Bacteria in Liquid Hand Soaps Bacterial Species Frequency of Detection Klebsiella oxytoca 30 Klebsiella pneumoniae 29 Enterobacter aerogenes 13 Serratia marcescens 12 Pseudomonas aeruginosa 7 Citrobacter koseri / farmeri 3 Enterobacter cloacae 2 Enterobacter gergoviae 2 Serratia odorifera 1 Serratia liquefaciens 1 Pantoea spp.
A variety of enteric bacteria were also identified, including Citrobacter koseri, Enterobacter intermedius, Hafnia alvei, Proteus vulgaris, Providencia rettgeri, and Serratia spp.
oxytoca 5 - Citrobacter koseri 2 - Enterobacter cloacae 12 - 5 - 3 + Enterobacter aerogenes 5 - Citrobacter braaki 1 - C.
AVYCAZ is also indicated for the treatment of complicated urinary tract infections (cUTI) including pyelonephritis caused by the following susceptible microorganisms: Escherichia coli, Klebsiella pneumoniae, Citrobacter koseri, Enterobacter aerogenes, Enterobacter cloacae, Citrobacter freundii, Proteus spp.
Gardnerella vaginalis Clinical isolates Rothia dentocariosa Clinical isolates Common uropathogens Alcaligenes faecalis Clinical isolates Candida albicans Clinical isolates Citrobacter koseri Clinical isolates Escherichia coli Clinical isolates Hemolytic streptococcus group A Clinical isolates Hemolytic streptococcus group B Clinical isolates Klebsiella oxytoca Clinical isolates K.
Listeria monocytogenes Staphylococcus saprophyticus Streptococcus agalactiae Streptococcus mitis Streptococcus Groups C, G and F Acinetobacter baumannii Acinetobacter calcoaceticus Citrobacter freundii Citrobacter koseri Enterobacter aerogenes Enterobacter cloacae Morganella morganii Neisseria gonorrhoeae Proteus vulgaris Pseudomonas stutzeri Clostridium perfringens Propionibacterium acnes Chlamydia pneumoniae Legionella pneumophila Mycobacterium avium Mycobacterium marinum Mycoplasma pneumoniae
AVYCAZ is indicated for the treatment of cUTI including pyelonephritis caused by the following susceptible microorganisms: Escherichia coli, Klebsiella pneumoniae, Citrobacter koseri, Enterobacter aerogenes, Enterobacter cloacae, Citrobacter freundii, Proteus spp.
DNA extracts from selected pathogens, including agents that are most commonly encountered in cases of hospitalacquired pneumonia (14), were tested: Enterobacter aerogenes, Proteus mirabilis, Citrobacter freundii, Escherichia coli, Citrobacter koseri, Klebsiella pneumoniae, Enterobacter cloacae, Serratia marcescens, Haemophilus influenzae, Moraxella catarrhalis, Acinetobacter baumanii, Stenotrophomonas maltophila, Pseudomonas aeruginosa, Bacteroides fragilis, Prevotella intermedia, Streptococcus pneumoniae, Streptococcus oralis, Staphylococcus aureus, Staphylococcus epidermidis, Candida albicans, CMV, HSV1, and adenovirus.
coli and 2 strains of Citrobacter koseri were positive through the P/Case TEST for production of penicillinase, cephalosporinase, or both (Table 1).